Talc litigation
Pending talc claims create uncertain legal costs, potential judgments, and reputational exposure that may persist despite defense and resolution efforts.
Source-verified risk research
Research updated: Jul 12, 2026, 12:00 AM UTCJohnson & Johnson operates in Pharmaceuticals within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.
Pending talc claims create uncertain legal costs, potential judgments, and reputational exposure that may persist despite defense and resolution efforts.
Biosimilar or generic competition, government price negotiations, and payer pressure can reduce sales and margins for key medicines.
Pipeline assets and medical devices may fail trials, face approval delays, encounter safety findings, or fall short of commercial adoption expectations.
Fetched: 7/12/2026, 12:00:00 AM UTC
Open original source